On certain problems of diagnosis, treatment and prospects for the rehabilitation of patients with circulatory diseases after coronavirus infection COVID-19 (literature review)

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The review presents the current problems of the combination of a new coronavirus infection COVID-19 and circulatory diseases. The results of studies on the indicated problem, the complexity of patient management, the combination of viral infection and concomitant pathology of the cardiovascular system are discussed. Data on the features of antiviral therapy in combination with cardiovascular drugs were analyzed. Assessment of the quality of life of patients after coronavirus infection using the Russian version of the “Medical Outcomes Study – Short Forms” questionnaire, will make it possible to clarify the tactics of medical and social rehabilitation of patients in this group.

Full Text

Restricted Access

About the authors

E. I. Bugaeva

City Clinical Hospital n.a. Prof. A.M. Voyno-Yasenetsky

Author for correspondence.
Email: bugayeva.1975@list.ru
Russian Federation, Khabarovsk

K. V. Zhmerenetsky

Far Eastern State Medical University

Email: bugayeva.1975@list.ru
Russian Federation, Khabarovsk

S. V. Dyachenko

City Clinical Hospital n.a. Prof. A.M. Voyno-Yasenetsky

Email: bugayeva.1975@list.ru
Russian Federation, Khabarovsk

References

  1. Богачевская С.А., Бондарь В.Ю., Капитонен-ко Н.А., Богачевский А.Н. Эпидемиология болезней системы кровообращения, требующих применения высокотехнологичных видов медицинской помощи, в Российской Федерации за последние 10 лет: статистические «пробелы». Дальневосточный медицинский журнал. 2015;2:112–16. [Bogachevskaya S.A., Bondar V.Y., Kapitonenko N.A., Bogachevskii A.N. Epidemiology of diseases of the circulatory system requiring the use of high-tech types of medical care in the Russian Federation over the past 10 years: statistical «gaps». Dal’nevostochnyi meditsinskii zhurnal. 2015;2:112–16. (In Russ.)].
  2. Сон И.М., Стародубов В.И., Маношкина Е.М., Ступак В.С. Тенденции показателей заболеваемости и больничной летальности от болезней системы кровообращения на фоне новой коронавирусной инфекции COVID-19. Профилактическая медицина. 2021;24(11):7–14. [Son I.M. Starodubov V.I. Manoshkina E.M. Stupak V.S. Trends in morbidity and hospital mortality rates from diseases of the circulatory system against the background of a new coronavirus infection COVID-19. Profilakyicheskaya Meditsina. 2021;24(11):7–14. (In Russ.)].
  3. Богачевская С.А. Динамика заболеваемости болезнями системы кровообращения населения России и Дальневосточного региона с прогнозом к 2018 г. Дальневосточный медицинский журнал. 2017;2:40–3. [Bogachevskaya S.A. Dynamics of the incidence of diseases of the circulatory system of the population of Russia and the Far East region with a forecast by 2018. Dal’nevostochnyi meditsinskii zhurnal. 2017;2:40–3. (In Russ.)].
  4. Здравоохранение в России. 2021: Статистический сборник Росстат. 2021;З–46:171. [Health care in Russia. 2021: Statistical collection of Rosstat. 2021;3–46:171. (In Russ.)].
  5. Барбараш О.Л., Каретникова В.Н., Кашталап В.В. и др. Новая коронавирусная болезнь (COVID-19) и сердечно-сосудистые заболевания. Комплексные проблемы сердечно-сосудистых заболеваний. 2020;9(2):17–28. [Barbarash O.L., Karetnikova V.N., Kashtalap V.V., et al. Novel coronavirus disease (COVID-19) and cardiovascular disease. Kompleksnie problemi serdechno_sosudistih zabolevanii. 2020;9(2):17–28. (In Russ.)]. doi: 10.17802/2306-1278-2020-9-2-17-28.
  6. Ощепкова С.Ю., Зязева И.П., Петухова И.В. Сравнительная характеристика течения сердечно-сосудистых заболеваний у пациентов, перенесших COVID-19-инфекцию и без нее. Международный студенческий научный вестник. 2021;3. [Oschepkova S.Yu., Zyazeva I.P., Petuhova I.V. Comparative characteristics of the course of cardiovascular diseases in patients with and without COVID-19 infection. Mejdunarodnyi Studencheskii Nauchnyi Vestnik. 2021;3. (In Russ.)].
  7. Task Force for the management of COVID-19 of the European Society of Cardiology. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis. Eur Heart J. 2022;43(11):1033–58. doi: 10.1093/eurheartj/ehab696. Erratum in: Eur Heart J. 2021;20.
  8. Явелов И.С. COVID-19 и сердечно-сосудистые заболевания. Международный журнал сердца и сосудистых заболеваний. 2020. 27 c. [Yavelov I.S. COVID-19 and cardiovascular disease. Mezhdunarodnyi zhurnal serdtsa i sosudistykh zabolevanii. 2020. 27 p. (In Russ.)].
  9. Guo T., Fan Y., Chen M., et al. Cardiovascular Implications of Fatal Outcomes of Patients with Coronavirus Disease 2019 (COVID-19). JAMA. Cardiol. 2020;5(7):811–18. doi: 10.1001/jamacardio.2020.1017.
  10. Myers L.C., Parodi S.M., Escobar G.J., Liu V.X. Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California. JAMA. 2020;323(21):2195–98. doi: 10.1001/jama.2020.7202.
  11. Шляхто Е.В., Конради А.О., Виллевальде С.В. и др. Руководство по диагностике и лечению болезней системы кровообращения (БСК) в контексте пандемии COVID-19. РКЖ. 2020;3. [Shlyahto E.V., Konradi A.O., Villevalde S.V., et al. Guidelines for the diagnosis and treatment of circulatory system diseases (CVD) in the context of the COVID-19 pandemic. RKJ. 2020;3. (In Russ.)].
  12. Романов Б.К. Коронавирусная инфекция COVID-2019. Безопасность и риск фармакотерапии. 2020;1. [Romanov B.K. Coronavirus infection COVID-2019. Bezopasnost i risk farmakoterapii. 2020;1:(In Russ.)].
  13. Clerkin K.J., Fried J.A., Raikhelkar J., et al. COVID-19 and Cardiovascular Disease. Circulation. 2020;141(20):1648–1655. doi: 10.1161/CIRCULATIONAHA.120.046941.
  14. Driggin E., Madhavan M.V., Bikdeli B., et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic. J Am Coll Cardiol. 2020. doi: 10.1016/j.jacc.2020;03:031.
  15. Zheng Y.Y., Ma Y.T., Zhang J.Y., Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259–60. doi: 10.1038/s41569-020-0360-5.
  16. Mozaffarian D., Benjamin E.J., Go A.S., et al. Heart disease and stroke statistics-2016 update a report from the American Heart Association. Circulation. 2016;133(4):38–360. doi: 10.1161/CIR.0000000000000350.
  17. Hughes B.B., Kuhn R., Peterson C.M., et al. Projections of global health outcomes from 2005 to 2060 using the International Futures integrated forecasting model. Bull. WHO. 2011;89:478–86. doi: 10.2471/BLT.10.083766.
  18. Townsend N., Wilson L., Bhatnagar P., et al. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37(42):3232–45. doi: 10.1093/eurheartj/ehw334.
  19. Komalasari R., Nurjanah, Yoche M.M. Quality of Life of People with Cardiovascular Disease: A Descriptive Study. Asian Pac Isl Nurs J. 2019;4(2):92–6. doi: 10.31372/20190402.1045.
  20. Глущенко В.А., Ирклиенко Е.К. Сердечно-сосудистая заболеваемость - одна из важнейших проблем здравоохранения. Медицина и организация здравоохранения. 2019;1. [Gluschenko V.A., Irklienko E.K. Cardiovascular morbidity is one of the most important public health problems. 2019;1. (In Russ.)].
  21. Connolly Ph., Aaronson I., Jeremy P.T., Ward M.J. The cardiovascular system at a glance (4th ed.). Chichester, West Sussex: Wiley-Blackwell. 2013. Р. 88–9.
  22. Егорова А.Г., Романова А.Н. К вопросу влияния социально-гигиенических факторов на формирование болезней системы кровообращения. Экология и здоровье человека на Севере. Сборник материалов IV конгресса с международным участием. 2013. С. 209–14. [Egoro- va A.G., Romanova A.N. On the issue of the influence of social and hygienic factors on the formation of diseases of the circulatory system. Ecology and human health in the North. Collection of materials of the IV Congress with international participation. 2013. Р. 209–14. (In Russ.)].
  23. Драпкина О.М., Дроздова Л.Ю., Агеев Ф.Т. и др. Оказание амбулаторно-поликлинической медицинской помощи пациентам с хроническими заболеваниями, подлежащим диспансерному наблюдению, в условиях пандемии COVID-19. М., 2021. 109 с. [Drapkina O.M. Drozdova L.Yu., Ageev F.T., et al. Provision of outpatient medical care to patients with chronic diseases subject to dispensary observation during the COVID-19 pandemic. M., 2021. 109 p. (In Russ.)].
  24. Hunt B., Rotter A., McClintock C. Practical guidance for the prevention of thrombosis and management of coagulopathy and disseminated intravascular coagulation of patients infected with COVID-19. URL: https://thrombosisuk.org/downloads/T&H%20and%20COV-ID.pdf.2020.
  25. Brugliera L., Spina A., Castellazzi P., et al. Rehabilitation of COVID-19 patients. J Rehab Med. 2020;52(4):jrm00046. doi: 10.2340/16501977-2678.
  26. Иванова Г.Е., Мельникова Е.В., Левин О.С. и др. Актуальные вопросы реабилитации пациентов с инсультом на фоне новой коронавирусной инфекции (COVID-19). Резолюция Совета экспертов. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2020;120(8 2):81 7. [Ivanova G.E., Melnikova E.V., Levin O.S. et al. Actual issues of rehabilitation of patients with stroke against the background of a new coronavirus infection (COVID-19). Resolution of the Council of Experts Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. Spetsvypuski. 2020;120(8 2):81–7. (In Russ.)].
  27. Бубнова М.Г., Шляхто Е.В., Аронов Д.М. и др. Новая коронавирусная инфекционная болезнь COVID-19: особенности комплексной кардиологической и респираторной реабилитации. РКЖ. 2021;5. [Bubnova M.G., Shlyahto E.V., Aronov D.M. et al. New coronavirus infectious disease COVID-19: features of complex cardiological and respiratory rehabilitation. RKJ. 2021;5 (In Russ.)].
  28. Gaziano O. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020. doi: 10.1001/jama.2020.4683.
  29. Bischof E., Chen G., Ferretti M.T. Understanding COVID-19 new diagnostic guidelines – a message of reassurance from an internal medicine doctor in Shanghai. Swiss Med. Wkly. 2020;150:20216. doi: 10.4414/smw.2020.20216.
  30. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145–51. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003.
  31. Gupta A., Madhavan M.V., Sehgal K., et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26(7):1017–32. doi: 10.1038/s41591-020-0968-3.
  32. Bornstein S.R., et al. Practical recommendations for the management of diabetes in patients with COVID-19. www.thelancet.com/diabetes-endocrinology Published online. 2020. doi: 10.1016/S2213-8587(20)30152-2.
  33. You B., Ravaud A., Canivet A., et al. The official French guidelines to protect patients with cancer against SARS-CoV-2 infection. Lancet. Oncol. 2020;21(5):619–21. doi: 10.1016/S1470-2045(20)30204-7.
  34. Zhao M., Wang M., Zhang J., et al. Advances in the relationship between coronavirus infection and cardiovascular diseases. Biomed. Pharmacother. 2020;127:110230. doi: 10.1016/j.biopha.2020.110230.
  35. Xu Z., Shi L., Wang Y., et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet. Respir. Med. 2020;8(4):420–22. doi: 10.1016/S2213-2600(20)30076-X.
  36. Astuti I., Ysrafil. Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response. Diab Metab Syndr. 2020;14(4):407–12. doi: 10.1016/j.dsx.2020.04.020.
  37. Zhou F., Yu T., Du R., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62. doi: 10.1016/S0140-6736(20)30566-3.
  38. Puelles V.G., Lгtgehetmann M., Lindenmayer M.T., et al. Multi organ and renal tropism of SARS-CoV-2. N Engl J Med. 2020;38(6): 590–92. doi: 10.1056/NEJMc2011400.
  39. Klok F.A., Kruip M.J., HA van der Meer N.J.M., et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–47. Doi: 10.1016/j thromres.2020.04.013.
  40. Cascella M., Rajnik M., Cuomo A., et al. Features, Evaluation and Treatment Coronavirus (COVID-19). Treasure Island (FL): StatPearls Publishing, 2020.
  41. Рыбакова М.Г., Карев В.Е., Кузнецова И.А. Патологическая анатомия новой коронавирусной инфекции COVID-19. Первые впечатления. Архив патологии. 2020;82(5):5–15. [Ribako-va M.G., Karev V.E., Kuznecova I.A. Pathological anatomy of the new coronavirus infection COVID-19. First impressions. Arkhiv patologii. 2020;82(5):5–15. (In Russ.)].
  42. Грановская М.В., Заславская К.Я. COVID-19 ‒ набор симптомов или системная патология? Клиническая лекция. Часть 1. Особенности полиорганных нарушений. Инфекционные болезни: новости, мнения, обучение. 2020;3:3–9. [Granovskaya M.V., Zaslavskaya K.Ya. COVID-19 – a set of symptoms or a systemic pathology? Clinical lecture. Part 1. Features of multiple organ disorders. Infektsionnye bolezni: novosti, mneniya, obuchenie. 2020;3:3–9. (In Russ.)]. doi: 10.33029/2305-3496-2020-9-3S-3-9.
  43. Александрова Г.А., Вайсман Д.Ш. Об использовании правил МКБ-10 при постановке посмертного диагноза, кодировании и выборе первоначальной причины смерти при травмах и заболеваниях, связанных с COVID-19. Судебная медицина. 2020;6(2):4–7. [Aleksandrova G.A., Vaisman D.Sh. On the use of ICD-10 rules in post-mortem diagnosis, coding and selection of the underlying cause of death for injuries and illnesses associated with COVID-19. meditsina. 2020;6(2):4–7. doi: 10.19048/2411-8729-2020-6-2-4-7. (In Russ.)].
  44. Niforatos J., Melnick E.R., Faust J.S. Covid-19 fatality is likely overestimated. BMJ. 2020;368:m1113. doi: 10.1136/bmj.m1113.
  45. Joyce T. Coronavirus: Singapore scientists on the front lines of fight against Covid-19. The Straits Times. 2020. URL: https://www.straitstimes.com/singapore/health/singapore-scientists-on-the-front-lines-of-fight-against-covid-19.
  46. Kociol R.D., Cooper L.T., Fang J.C. Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association. Circulation. 2020;141:e69–92. doi: 10.1161/CIR.0000000000000745.
  47. Siripanthong B., Nazarian S., Muser D., et al. Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020;17(9):1463–71. doi: 10.1016/j.hrthm.2020.05.001.
  48. Шляхто Е.В., Конради А.О., Виллевальде С.В и др. Руководство по диагностике и лечению болезней системы кровообращения (БСК) в контексте пандемии COVID-19. РКЖ. 2020;3. [Shlyahto E.V., Konradi A.O., Villevalde S.V., et al. Guidelines for the diagnosis and treatment of circulatory system diseases (CVD) in the context of the COVID-19 pandemic. RKJ. 2020;3. (In Russ.)].
  49. Zhang L., Feng X., Zhang D., et al. Deep Vein Thrombosis in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: Prevalence, Risk Factors, and Outcome. Circulation. 2020;142(2):114–28.Doi: 10.1161/ CIRCULATIONAHA.120.046702.
  50. Batlle D., Wysocki J., Satchell K. Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? Clin Sci. 2020;134(5):543–45. doi: 10.1042/CS20200163.
  51. Richter D., Guasti L., Koehler F., et al. Late phase of COVID-19 pandemic in General Cardiology. A position paper of the ESC Council for Cardiology Practice. ESC. Heart Fail. 2021.
  52. Ачабаева А.Б., Хозаев М.К., Калмыкова А.А. и др. Оценка эффективности комплексной реабилитации после COVID-19: систематизация результатов наблюдений. Медицина. Социология. Философия. Прикладные исследования. 2022;2. [Achabaeva A.B., Hozaev M.K., Kalmikova A.A., et al. Evaluation of the effectiveness of complex rehabilitation after COVID-19: systematization of the results of observations. Meditsina. Sotsiologiya. Filosofiya. Prikladnye Issledovaniya. 2022;2. (In Russ.)].
  53. Pavy В., Iliou M.C., Meurin P., et al. Functional Evaluation and Cardiac Rehabilitation Working Group of the French Society of Cardiology. Safety of exercise training for cardiac patients: results of the French registry of complications during cardiac rehabilitation. Arch Intern Med. 2006;166(21):2329–34. doi: 10.1001/archinte.166.21.2329.
  54. Dixit S., Borghi-Silva A., Bairapareddy K.C. Revisiting pulmonary rehabilitation during COVID-19 pandemic: A narrative review. Rev Cardiovasc Med. 2021;22:315–27. doi: 10.31083/j.rcm2202039.
  55. Бубнова М.Г., Персиянова-Дуброва А.Л., Лямина Н.П., Аронов Д.М. Реабилитация после новой коронавирусной инфекции (COVID-19): принципы и подходы. CardioСоматика. 2020;4. [Bubnova M.G., Persiyanova_Dubrova A.L., Lyamina N.P., Aronov D.M. Rehabilitation after novel coronavirus infection (COVID-19): principles and approaches. CardioSomatika. 2020;4. (In Russ.)].
  56. Wang T.J., Chau B., Lui M., Physical medicine and rehabilitation and pulmonary rehabilitation for COVID-19. Am J Phys Med Rehab. 2020;99:769–74. doi: 10.1097/PHM.0000000000001505.
  57. Амирджанова В.Н., Горячев Д.В., Коршунов Н.И. Популяционные показатели качества жизни по опроснику SF-36 (результаты многоцентрового исследования качества жизни «МИРАЖ». Научно-практическая ревматология. 2008;1:36–48. [Amirdjanova V.N., Gorya- chev D.V., Korshunov N.I. Population indicators of quality of life according to the SF-36 questionnaire (results of the MIRAGE multicenter study of quality of life. Nauchno-Prakticheskaya Revmatologiya. 2008;1:36–48. (In Russ.)].
  58. Ware J.E., Snow К.К., Kosinski М., Gandek В. Sf-36 Health Survey. Manuel and Interpretation Guide, Lincoln, Rl’. Quality Metric. Incorporated. 2000. 150 p.
  59. Индукаева Е.В., Макаров С.А., Жиляева Т.П., Груздева О.В. Мониторинг качества жизни, психологического статуса и приверженности лечению у пациентов при проведении профилактических мероприятий в территориальной поликлинике. Кардиоваскулярная терапия и профилактика. 2018;17(1):61–8. [Indukaeva E.V., Makarov S.A., Jilyaeva T.P., Gruzdeva O.V. Monitoring the quality of life, psychological status and adherence to treatment in patients during preventive measures in the territorial polyclinic. Kardiovaskulyarnaya terapiya i profilaktika. 2018;17(1):61–8. (In Russ.)]. doi: 10.15829/1728-8800- 2018-1-61-68.
  60. WHO. Quality of life group. What is it Quality of life? Wid. Hth. Forum. 1996. 29 р.
  61. Ware J.E. Conceptualization and Measurement of Health-Related Quality of Life: Comments on an Evolving Fiel. Arch Phys Med Rehabilit. 2003;84(4 suppl 2):43–51. doi: 10.1053/apmr.2003.50246.
  62. Vicchio M., Feo M.D., Giordano S., et al. Coronary artery bypass grafting associated to aortic valve replacement in the elderly: survival and quality of life. J Cardiothorac Surg. 2012;7:13. doi: 10.1186/1749-8090-7-13.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies